Leads science and technology for a healthcare testing business, covering R&D, biomarker development, clinical validation, service implementation, partnerships, and team design.
About this role
The position is in NEC’s AI Drug Discovery Division, within a translational research team collaborating with pharmaceutical companies and overseas research groups. The team connects drug-discovery AI research with validation, proposals, and business-development support across cancer, infectious disease, and autoimmune disease programs.
Work includes leading clinical study planning and execution for immunotherapy, assessing the biological validity and clinical applicability of AI-derived insights, and planning validation experiments when needed. The researcher will analyze data, report to internal and external stakeholders, prepare scientific overviews, executive summaries, data visualizations, and technical documents, and join technical due diligence for external technologies.
Applicants need a Ph.D. in immunology, virology, oncology, or a related field, plus at least two years of practical experience in a pharmaceutical or biotechnology company and experience collaborating on project teams with overseas members.
This is an AI-generated summary of the employer's original posting — details can be incomplete, out of date or simply wrong. Always confirm everything on the official posting before applying.